Medicina

PESQUISA DE DOENÇA , CHAMADA CADISIL .

2007-03-22 01:04:36 · 3 respostas · perguntado por RAFAEL P 1

21/03/2007 - 19h49 Uol
PARIS, 21 mar (AFP) - Suponha que um vírus mortal cruzou o planeta e você, em seu laboratório doméstico, desenvolveu duas substâncias: uma é uma vacina e a outra é um líquido tóxico fatal, mas você não sabe qual é qual.

Você tem duas pessoas sob seus cuidados e a única forma de identificar a vacina é injetar em cada uma delas uma das substâncias. Você mataria uma das pessoas para salvar muitas outras vidas?

2007-03-22 00:47:32 · 2 respostas · perguntado por Vendo a Vida Colorida 4

2007-03-21 20:35:52 · 8 respostas · perguntado por Tenho Duvidas 1

2007-03-21 20:35:04 · 3 respostas · perguntado por Tenho Duvidas 1

A TEORIA DA EVOLUÇÃO oferece alguma explicação para as diferenças observadas no funionamento dos cérebros do homem e da mulher?

2007-03-21 15:33:02 · 4 respostas · perguntado por heitor_goulart 1

2007-03-21 07:47:12 · 8 respostas · perguntado por lenebcarvalho 5

e o fontículo posterior superior?? será fechado pela união de quais ossos?

2007-03-21 03:46:08 · 1 respostas · perguntado por Anonymous

2007-03-21 02:47:52 · 1 respostas · perguntado por patricia s 1

O que acontece com o cerebro e com nosso sitema nervoso que as vezes, faz com que fiquemos irritados com a voz de uma pessoa? ou com uma brincadeirinha?

Dizem que a TMP e a menopausa na mulher a deixa mais irritada. É verdade? Porque?

Por que dizem que maracujá e camomila acalmam? é verdade? Funciona mesmo?

2007-03-21 00:47:08 · 4 respostas · perguntado por Lia 2

Tem algo que faz perder o sono???

2007-03-21 00:31:22 · 7 respostas · perguntado por Tenho Duvidas 1

2007-03-21 00:23:31 · 7 respostas · perguntado por Thygho 6

dizem que o cérebro ativa uma substância qdo sentimos prazer, por exemplo: ao comer chocolate. Qual o nome dessa substância?

2007-03-20 23:51:58 · 5 respostas · perguntado por fafa 1

2007-03-20 16:35:38 · 4 respostas · perguntado por Tenho Duvidas 1

Dr. Allan Collins may be the most influential kidney specialist in the country. He is president of the National Kidney Foundation and director of a government-financed research center on kidney disease.
In 2004, the year he was chosen as president-elect of the kidney foundation, the pharmaceutical company Amgen, which makes the most expensive drugs used in the treatment of kidney disease, underwrote more than $1.9 million worth of research and education programs led by Dr. Collins, according to records examined by The New York Times. In 2005, Amgen paid Dr. Collins at least $25,800, mostly in consulting and speaking fees, the records show.
The payments to Dr. Collins and the research center appear in an unusual set of records. They come from Minnesota, the first of a handful of states to pass a law requiring drug makers to disclose payments to doctors. The Minnesota records are a window on the widespread financial ties between pharmaceutical companies and the doctors who prescribe and recommend their products. Patient advocacy groups and many doctors themselves have long complained that drug companies exert undue influence on doctors, but the extent of such payments has been hard to quantify.
The Minnesota records begin in 1997. From then through 2005, drug makers paid more than 5,500 doctors, nurses and other health care workers in the state at least $57 million. Another $40 million went to clinics, research centers and other organizations. More than 20 percent of the state’s licensed physicians received money. The median payment per consultant was $1,000; more than 100 people received more than $100,000.
Doctors receive money typically in return for delivering lectures about drugs to other doctors. Some of the doctors receiving the most money sit on committees that prepare guidelines instructing doctors nationwide about when to use medicines. Dr. Collins, who received more money than anyone else in the state, is among a limited number whose payments financed research.
In dozens of interviews, most doctors said that these payments had no effect on their care of patients.
Dr. Collins said his sole focus was the health and well-being of patients. “Just because I might do consulting work doesn’t mean I don’t press the agenda of the public health,” he said.
Ken Johnson, senior vice president of Pharmaceutical Research and Manufacturers of America, said interactions between drug companies and doctors were beneficial. “In the end, patients are well-served when technically trained pharmaceutical research company representatives work with health care professionals to make sure medicines are used properly,” he said.
There is nothing illegal about doctors’ accepting money for marketing talks, and professional organizations have largely ignored the issue.
But research shows that doctors who have close relationships with drug makers tend to prescribe more, newer and pricier drugs — whether or not they are in the best interests of patients.
“When honest human beings have a vested stake in seeing the world in a particular way, they’re incapable of objectivity and independence,” said Max H. Bazerman, a professor at Harvard Business School. “A doctor who represents a pharmaceutical company will tend to see the data in a slightly more positive light and as a result will overprescribe that company’s drugs.”
In an e-mail message, Dr. Collins said he personally received in 2004 less than $10,000 from Amgen for educational presentations. “The contract amount of $1.9 million from Amgen was paid to the Minneapolis Medical Research Foundation (MMRF) for the research contract, on which I am the designated senior researcher,” Dr. Collins wrote. He wrote that he did not work for or serve on the board of directors of the foundation. Dr. Collins discloses on his Web site and research papers that he is a consultant to Amgen, among other companies.
Dan Whelan, an Amgen spokesman, said the company paid the Minneapolis Medical Research Foundation “to conduct sophisticated research and data analyses that have enhanced the understanding of health care delivery” for kidney patients.
But Dr. Daniel Coyne, a kidney specialist at Washington University, said he was troubled by the payments.
“Amgen’s funding for Dr. Collins’s MMRF is another huge financial connection to individuals at the National Kidney Foundation,” Dr. Coyne said. “The foundation’s recent pro-industry anemia guidelines — and the revisions due next month — have to be viewed with great skepticism.”

2007-03-20 16:23:11 · 6 respostas · perguntado por zeca do trombone 5

2007-03-20 13:16:32 · 5 respostas · perguntado por a 1

2007-03-20 08:55:58 · 5 respostas · perguntado por Dias D 1

2007-03-20 06:50:51 · 7 respostas · perguntado por suncler 3

Me gustaría intentar un remedio de este tipo.

2007-03-20 04:23:49 · 3 respostas · perguntado por nycti2000 1

2007-03-20 02:08:51 · 5 respostas · perguntado por Sinapse 2

2007-03-19 13:26:42 · 6 respostas · perguntado por Peter Punk 4

se tenho megaesofágo nivel três e vai até nivel quatro.oque acontece quando chega nesse que é considerado ultimo nivel?obrigada.

2007-03-19 12:24:29 · 1 respostas · perguntado por teresinhabprates 6

2007-03-19 09:32:49 · 9 respostas · perguntado por Anonymous

2007-03-19 08:13:09 · 4 respostas · perguntado por PAULINO B 2

PAN - hormônio peptideo das células miocárdicas atriais / peptideo atrial natiuretico

2007-03-19 05:12:04 · 2 respostas · perguntado por Bruno A 1

2007-03-19 05:04:47 · 4 respostas · perguntado por tózeca 4

biociência

2007-03-19 04:53:19 · 3 respostas · perguntado por renan a 1

tenho um filho de 16 anos ele nunca havia tido qualquertipode problema de saude ,agora no carnaval ele teve uma convulsao seguida de outra depois de 30 minuto (isso ja dentro do hospital...agora ele vem tendo estas convusões e reclama que o lado esquerdo do corpo as vezes fica paralisado (ele perde totalmene a mobilidade,nao consegue andar etc...ele esta tomoando no momento oxcarbamezepina...mas os efeitos colaterais do remedio sao muito fortes ...e o lado esquerdo perna esquerda e braço esquerda e braço esquerdo continuam com problemas,...hoje quase ele convulsionou novamente ,que puder ajudar ou conhercer o caso e puder falar um pouco sobre o assunto agradeço muito.

2007-03-18 15:38:45 · 4 respostas · perguntado por cavalheirojet 1

2007-03-18 14:26:10 · 10 respostas · perguntado por tózeca 4

Tenho polio parcial na perna direita. A mesma atrofiou na bacia e a perna deste lado e fiquei sem movimento apenas na aticulação do calcanhar e com movimentos mínimos em dois dedos dos pés. Tenho visto alguns avanços na aplicação de celulas-troncos e gostaria de saber se já existe alguma experiência neste campo com relação a este maldito vírus. E também como participar como voluntário de experimentos sérios neste campo.

2007-03-18 13:49:30 · 4 respostas · perguntado por Nathal 1

HAa

2007-03-18 11:17:49 · 9 respostas · perguntado por Anonymous